Survival Rates According to Tumour Location in Patients With Surgically Treated Oral and Oropharyngeal Squamous Cell Carcinoma

Anticancer Res. 2019 May;39(5):2527-2533. doi: 10.21873/anticanres.13374.

Abstract

Background/aim: We evaluated survival rates in surgically-treated oral and oropharyngeal squamous cell carcinoma patients at our clinic, and determined whether survival differed by tumour locations.

Patients and methods: In a retrospective study, tumour lesions in 1,486 patients were categorized into 6 groups according to tumour location. Patients' age, sex, tumour-node-metastasis classification, resection status, 5-year and disease-specific survival rates were statistically analysed between groups.

Results: A significantly inferior disease-specific and lower 5-year survival rates for tumours located at the base of the tongue and oropharynx, and maxilla, due to higher T-stage and incomplete resection status were shown. Cervical lymph node metastasis and distant metastatic spread were more frequently observed with base of the tongue and oropharynx lesions.

Conclusion: Attentive inspection and precise clinical examinations of specific oral and oropharyngeal regions are crucial for early diagnosis and treatment. Oral and oropharyngeal tumour locations play important roles in disease prognosis.

Keywords: Squamous cell carcinoma; oral cancer; oropharyngeal cancer; surgical treatment; survival rates; tumor location.

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Lymphatic Metastasis / pathology
  • Male
  • Maxilla / pathology
  • Middle Aged
  • Mouth Floor / pathology
  • Mouth Neoplasms / epidemiology
  • Mouth Neoplasms / pathology
  • Mouth Neoplasms / surgery*
  • Neoplasm Staging
  • Oral Surgical Procedures
  • Oropharyngeal Neoplasms / epidemiology
  • Oropharyngeal Neoplasms / pathology
  • Oropharyngeal Neoplasms / surgery*
  • Palate / pathology
  • Prognosis*
  • Squamous Cell Carcinoma of Head and Neck / epidemiology
  • Squamous Cell Carcinoma of Head and Neck / pathology
  • Squamous Cell Carcinoma of Head and Neck / surgery*
  • Survival Rate